Young and Partners

Annual Revenue Estimate: $10m+

AUM: NA

Email Convention: [email protected]

Overview

Overall Ranking (8%)

The Overall Ranking is a score from 1 star (very bad) to 5 stars (excellent) generated based on the Company Reviews of current and former employees at this company, taking everything into account.

The number you see in the middle of the donut pie chart is the simple average of these scores. If you hover over the various sections of the donut, you will see the % breakdown of each score given.

The percentile score in the title is calculated across the entire Company Database and uses an adjusted score based on Bayesian Estimates (to account for companies that have few reviews). Simply put, as a company gets more reviews, the confidence of a "true score" increases so it is pulled closer to its simple average and away from the average of the entire dataset.

The Overall Ranking is generated based on the Company Reviews.

2
  • 5 Stars
  • 4 Stars
  • 3 Stars
  • 2 Stars
  • 1 Star

Company Details

Young & Partners is an international investment banking firm uniquely dedicated to the chemical and life science industries. The Firm is a licensed broker-dealer and a member of the FINRA and SIPC. It is believed to be one of the largest chemical industry investment banking groups worldwide and is highly regarded in life sciences.

The Firm provides extensive services to large and middle market clients in the areas of:

Mergers
Acquisitions
Divestitures
Takeover defense
Financial restructuring and bankruptcy advisory services
Capital raising through private placements
General financial advice

The Firm's activities and projects are highly international in nature. For cross-border Brazilian transactions, the Firm has a joint venture partnership with a leading Brazilian investment bank, Virtus BR Partners.

The senior members of the Firm have completed a large number of transactions and financings for companies on a global basis over many years.

Compared to other investment banks, Young & Partners offers clients advantages in the following categories:

One of only a few independent investment banks focused solely on the chemical and life science industries
Well recognized and highly regarded in the industry
Emphasizes long-term relationships with clients
Extensive and focused knowledge of chemical and life science industry M&A and financing dynamics
Structured to provide consistent senior attention and involvement for all projects
Extensive and centralized senior contacts throughout the industry
Flexibility to assist clients in all types of transactions, regardless of size or type

The Firm has sponsored the leading Senior Chemical Executive Conference every fall for many years on "Strategic, Financial and Shareholder Issues for Chemical Executives".

The Firm co-sponsors an annual "Pharmaceutical Executive Summit" with Pharmaceutical Executive Magazine.

In addition, the Firm selectively engages in principal investing

Locations

Location

HQ

See in Google Maps

230 Park Avenue, New York, NY, 10169, United States

(212) 682-5555

Get Full Access

or Register to Contribute
.